Form 8-K - Current report:
SEC Accession No. 0001493152-25-028584
Filing Date
2025-12-19
Accepted
2025-12-19 17:00:33
Documents
13
Period of Report
2025-12-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 41403
  Complete submission text file 0001493152-25-028584.txt   252596

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE biaf-20251219.xsd EX-101.SCH 3768
3 XBRL DEFINITION FILE biaf-20251219_def.xml EX-101.DEF 26601
4 XBRL LABEL FILE biaf-20251219_lab.xml EX-101.LAB 36623
5 XBRL PRESENTATION FILE biaf-20251219_pre.xml EX-101.PRE 25225
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5762
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 251588383
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)